Safety, Efficacy Evaluation of Empagliflozin Administration for Neutropenia in Glycogenosis Type 1b and G6PC3 Deficiency

Clinical trial NCT04138251 · UNKNOWN

Trial details

NCT number: NCT04138251
Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Glycogen Storage Disease Type I Glucose 6 Phosphatase Deficiency

Start date: 2019-06-20
Primary completion: 2020-06-30
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.